Habibeh Khoshbouei

Stay informed with Habibeh Khoshbouei’s coverage and analysis for Fortune.

  • UNITED STATES – AUGUST 15: 30mg tablets of Shire Plc’s Adderall XR are arranged in a Cambridge, Massachusetts pharmacy on Tuesday, August 15, 2006. Shire Plc shares rose after the company settled a patent lawsuit with Barr Pharmaceuticals Inc., protecting Shire’s best-selling Adderall XR hyperactivity drug from cheaper rival copies until 2009. (Photo by Jb Reed/Bloomberg via Getty Images)Health

    Adderall can lead to a cycle of dependence in people who don’t really need it. For those who do, it can be a wonder drug. A neuroscientist explains why

    By Habibeh Khoshbouei and The Conversation